In this study, we measured PD‐1 expression on CD3 positive BM T‐lymphocytes in newly diagnosed adult Egyptian AML patients and its relation to clinical/prognostic parameters in addition to response to induction therapy (day 28). The gene discussed is PDCD1; the disease is acute myeloid leukemia.